Evidence map›Paper›PMID 38316628›Full record

ArticleThoracic cancer2024

Surgical resection of an intraluminal tumor in the azygos vein with an unknown primary site causing superior vena cava syndrome.

Yuki Monden, Dai Une, Hidejiro Torigoe, Tetsuya Isoda, Suzuka Kamaguchi, Kenji Yoshida, Yuji Hirami, Mikizo Nakai

Open access · goldAbstract readCase Reports
In one paragraph

Article in Thoracic cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yuki MondenDepartment of Cardiovascular Surgery, Okayama Medical Center, Okayama, Japan.ORCID 0009-0008-2066-592X
Dai UneDepartment of Cardiovascular Surgery, Okayama Medical Center, Okayama, Japan.
Hidejiro TorigoeDepartment of Thoracic Surgery, Okayama Medical Center, Okayama, Japan.
Tetsuya IsodaDepartment of Pathology, Okayama Medical Center, Okayama, Japan.
Suzuka KamaguchiDepartment of Cardiovascular Surgery, Okayama Medical Center, Okayama, Japan.
Kenji YoshidaDepartment of Cardiovascular Surgery, Okayama Medical Center, Okayama, Japan.
Yuji HiramiDepartment of Thoracic Surgery, Okayama Medical Center, Okayama, Japan.
Mikizo NakaiDepartment of Cardiovascular Surgery, Okayama Medical Center, Okayama, Japan.
Okayama Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intraluminal tumor in the azygos vein is a rare disease that can cause superior vena cava (SVC) syndrome. Radiotherapy and endovascular stenting with or without chemotherapy are reported to have a high clinical success rate for the management of SVC syndrome with malignancy, but a poor survival rate. Here, we report a 69-year-old man who presented with swelling of the face and upper extremities, who was diagnosed with SVC syndrome caused by an intraluminal tumor in the azygos vein. Enhanced chest computed tomography revealed an intraluminal mass with a filling defect from the azygos vein to the SVC, with no extravascular extension or dissemination of the primary tumor. Surgical resection of the mass en bloc with the azygos vein and SVC reconstruction was performed. A poorly differentiated carcinoma was diagnosed on postoperative pathological evaluation. Twelve months after resection, the patient was well with no signs of recurrent disease. This case highlights that surgical resection should be considered as a treatment of choice for the management of SVC syndrome caused by an intraluminal malignancy in the azygos vein.

Indexed as

Neoplasms, Unknown PrimarySuperior Vena Cava SyndromeAgedAzygos VeinHumansMaleTomography, X-Ray ComputedVena Cava, Superiorazygos veinsuperior vena cava syndromethoracic surgery

Identifiers

PMID38316628
PMCPMC10912538
OpenAlexW4391607773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.